AI assistant
Protagonist Therapeutics, Inc — Director's Dealing 2016
Aug 11, 2016
31163_dirs_2016-08-10_631d9e66-da81-418d-9e6d-2c717bb6e7bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2016-08-10
Reporting Person: SELICK HAROLD E (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.31 | 2019-05-14 | Common Stock (3310) | Direct | |
| Stock Option (right to buy) | $0.87 | 2023-09-26 | Common Stock (6196) | Direct | |
| Stock Option (right to buy) | $1.89 | 2024-10-22 | Common Stock (6490) | Direct | |
| Stock Option (right to buy) | $1.16 | 2025-10-28 | Common Stock (10724) | Direct | |
| Stock Option (right to buy) | $4.21 | 2026-04-29 | Common Stock (14299) | Direct |
Footnotes
F1: The option vests over a three-year period, with 1/36th of the shares subject to the option vesting each month following the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.
F2: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.
F3: The option vests over a four-year period, with 1/48th of the shares subject to the option vesting on the last day of each month following the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.